This issue of QuarterWatch analyzes MedWatch Reports from the third quarter of 2015. This issue identifies major differences in reports of cancer associated with drugs for psoriasis, a common skin disorder affecting an estimated 7.5 million people. While corticosteroid and other topical drugs are sufficient for many cases, potent immunosuppressant drugs are used in increasing numbers. This report also provides new evidence that drugs for erectile dysfunction and pulmonary arterial hypertension can cause deafness or sudden hearing loss.
More RSI News
Bias Assessment in Case-Control and Cohort Studies for Hazard Identification
IARC recently published a volume on quantitative bias modelling: Bias assessment in case–control and cohort studies for hazard identification (IARC Scientific Publication No. 171). We…
Read News ItemRSI Helps Strengthen Food Safety Culture in Vietnam
In mid-October 2025, Vietnamese and Canadian experts convened in Đà Nẵng to exchange approaches for strengthening food safety through risk science. The workshop brought together…
Read News ItemUse of Probabilistic Exposure Models in the Assessment of Dietary Exposure to Chemicals
Risk Sciences International CEO, Greg Paoli and RSI senior experts Emma Hartnett and Paul Price, have co-authored a new peer-reviewed publication highlighting the critical role…
Read News ItemAging and cognitive decline
Working with the College of Physicians and Surgeons of Alberta, Risk Sciences International conducted a wide-ranging review of aging and cognitive decline, with specific focus on aging physicians and fitness to practice. The publication in Aging & Mental Health documents domains of cognition that decline with older age, concerns with relying on physician self-reported competency, challenges with cognitive screening in older physicians, and a general data gap linking cognitive levels and fitness to practice.
Read News Item